Used as a key intermediate in the synthesis of kinase inhibitors, particularly in pharmaceutical research targeting cancer therapies. Its structure allows for selective modification to develop compounds with high affinity for specific enzyme targets. Commonly employed in the preparation of antitumor agents due to its ability to mimic purine bases, facilitating interaction with ATP-binding sites in kinases. Also utilized in the development of diagnostic probes and labeled compounds for biochemical assays.